USD10
AURA delen
Info over Aura BiosciencesAura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
USD10
AURA delen
Info over Aura BiosciencesAura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Statistieken
HANDELSVENSTER
Gesloten
OPENT OM
Onvoldoende gegevens
MARKTKAPITALISATIE
US$ 415,95 mln.
OPENINGSPRIJS
US$ 6,58
LAAG (1J)
US$ 4,35
HOOG (1J)
US$ 7,73
LAAG (24u)
US$ 6,45
HOOG (24H)
US$ 6,77
VOLUME (24 uur)
US$ 441,46K
40,17%
Prijsgeschiedenis
Time | Price | Change |
|---|---|---|
Vandaag | US$ 6,58 | |
1 dag | US$ 6,55 | 0,00% |
1 week | US$ 6,20 | |
1 maand | US$ 5,54 | |
1 jaar | US$ 7,00 |